DACS
ALMR

Dymon Asia Capital (Singapore)’s Alamar Biosciences ALMR Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio ALMR Stock Details ALMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Buy
+16,600
New +$376K 0.02% 211

Other funds holding ALMR

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s ALMR Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 16,600 shares worth $450K. The stake represents 0.02% of the portfolio and ranks #211 among its holdings.

9 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

  • Dymon Asia Capital (Singapore) held 16,600 shares of Alamar Biosciences worth $450K as of Q2 2026.
  • Alamar Biosciences was a new Dymon Asia Capital (Singapore) position in Q2 2026.
  • Alamar Biosciences made up 0.02% of Dymon Asia Capital (Singapore)'s portfolio in Q2 2026, its #211 holding.
  • 9 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.